Skip to main content
Indoco Remedies Ltd. logo

Indoco Remedies Ltd. — Investor Relations & Filings

Ticker · INDOCO ISIN · INE873D01024 LEI · 3358007XE9RRPHJA6U47 BSE.NS Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2023-10-09 Regulatory Filings
Country IN India
Listing BSE.NS INDOCO

About Indoco Remedies Ltd.

https://www.indoco.com/

Indoco Remedies Ltd. is a fully integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of finished dosages and Active Pharmaceutical Ingredients (APIs). The company operates multiple manufacturing facilities equipped to produce various dosage forms, including tablets, capsules, injectables, ophthalmics, and topical preparations. Its therapeutic portfolio spans stomatologicals, anti-infectives, respiratory, cardiovascular, anti-diabetics, and pain management. Indoco maintains a significant global footprint, exporting products to over 55 countries, including highly regulated markets such as the United States and Europe. The organization is recognized for its strong research and development capabilities, focusing on complex generics and niche formulations. Key brands include Sensodent-K, Febrex Plus, and Cyclopam, reflecting its leadership in specific therapeutic segments.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2023. It is addressed to stock exchanges and signed by the Company Secretary. The document is short (1288 characters) and primarily serves as a certification of compliance rather than containing financial data or detailed report content. It does not contain financial statements or substantive financial analysis. Therefore, it fits the criteria for a Regulatory Filing (RNS) as it is a compliance certificate and not a full financial or management report.
2023-10-09 English
Board Meeting — INDOCO REMEDIES LIMITED has informed the Exchange about Board Meeting to be held on 19-Oct-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for t…
Regulatory Filings
2023-10-06 English
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying them of an upcoming Board Meeting scheduled to consider and approve unaudited financial results for the quarter and half year ended September 30, 2023. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures related to board meetings. The document does not contain any financial data or results itself, nor does it include detailed financial analysis or reports. It is an announcement of a board meeting where financial results will be considered, not the results or report itself. Therefore, it fits the category of Board/Management Information (MANG), which includes announcements of board meetings and related disclosures.
2023-10-06 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying the closure of the trading window in compliance with SEBI regulations ahead of the announcement of quarterly and half-year financial results. It does not contain any financial data or results itself, nor does it present a report. Instead, it is an announcement related to insider trading restrictions prior to the release of financial results. The document length is short (1779 characters), and it serves as a regulatory notification rather than a report or detailed financial disclosure. Therefore, it fits best under Regulatory Filings (RNS).
2023-09-29 English
Shareholders meeting
Regulatory Filings
2023-09-27 English
Shareholders meeting
AGM Information Classification · 100% confidence The document is titled 'Proceedings of 76th Annual General Meeting of Indoco Remedies Limited' and details the events and discussions that took place during the AGM held on 26th September 2023. It includes information about the meeting's conduct, attendees, resolutions proposed and passed, and voting procedures. There is no full financial report or detailed financial statements included, but rather a summary of the AGM proceedings. This matches the definition of 'AGM Information' which covers presentations and materials shared during the Annual General Meeting. The document is over 5,000 characters and contains substantive content about the meeting itself, not just an announcement or a voting result. Therefore, the appropriate classification is AGM Information (AGM-R).
2023-09-27 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.